117 related articles for article (PubMed ID: 2340852)
1. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
Pace S; Longo A; Toon S; Rolan P; Evans AM
Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
[TBL] [Abstract][Full Text] [Related]
3. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
Rebouche CJ
Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
Parnetti L; Gaiti A; Mecocci P; Cadini D; Senin U
Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
[TBL] [Abstract][Full Text] [Related]
7. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver.
Mancinelli A; Longo A; Nation RL; Evans AM
Drug Metab Dispos; 2000 Dec; 28(12):1401-4. PubMed ID: 11095575
[No Abstract] [Full Text] [Related]
8. [Serum levels and urine excretion of L-carnitine in patients with normal and impaired kidney function].
Leschke M; Rumpf KW; Eisenhauer T; Becker K; Bock U; Scheler F
Klin Wochenschr; 1984 Mar; 62(6):274-7. PubMed ID: 6716912
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine and carnitine ester transport in the rat small intestine.
Marciani P; Lindi C; Marzo A; Arrigoni Martelli E; Cardace G; Esposito G
Pharmacol Res; 1991 Feb; 23(2):157-62. PubMed ID: 2062791
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
[TBL] [Abstract][Full Text] [Related]
13. Uptake of acetyl-L-carnitine in the brain.
Burlina AP; Sershen H; Debler EA; Lajtha A
Neurochem Res; 1989 May; 14(5):489-93. PubMed ID: 2747840
[TBL] [Abstract][Full Text] [Related]
14. Protein binding of L-carnitine family components.
Marzo A; Arrigoni Martelli E; Mancinelli A; Cardace G; Corbelletta C; Bassani E; Solbiati M
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():364-8. PubMed ID: 1820909
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
17. High uptake of [2-11C]acetyl-L-carnitine into the brain: a PET study.
Kuratsune H; Watanabe Y; Yamaguti K; Jacobsson G; Takahashi M; Machii T; Onoe H; Onoe K; Matsumura K; Valind S; Kitani T; Långström B
Biochem Biophys Res Commun; 1997 Feb; 231(2):488-93. PubMed ID: 9070306
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.
Walstad RA; Dahl K; Hellum KB; Thurmann-Nielsen E
Eur J Clin Pharmacol; 1988; 35(3):273-9. PubMed ID: 3053209
[TBL] [Abstract][Full Text] [Related]
19. Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
Gillen M; Valdez S; Zhou D; Kerr B; Lee CA; Shen Z
Drug Des Devel Ther; 2016; 10():3555-3562. PubMed ID: 27843295
[TBL] [Abstract][Full Text] [Related]
20. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
Mancinelli A; Longo A; Shanahan K; Evans AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1122-8. PubMed ID: 7562478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
